DavidMAronoffMDFIDSA, FAAM(He/Him)
Infectious Disease • Indianapolis, INJohn B. Hickam Professor of Medicine and Chair, Department of Medicine
Dr. Aronoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
545 Barnhill Drive
EH 305
Indianapolis, IN 46202Phone+1 317-274-8438
Summary
- Dr. David Aronoff is an infectious disease specialist in Indianapolis, IN and is Chair of the Department of Medicine in the Indiana University School of Medicine and the Indiana University Health system.
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 1998 - 2002- Vanderbilt University Medical CenterResidency, Internal Medicine, 1995 - 1998
Tufts University School of MedicineClass of 1995
Certifications & Licensure
IN State Medical License 2021 - 2025
TN State Medical License 1996 - 2025
KY State Medical License 2021 - 2022
MI State Medical License 2002 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol Start of enrollment: 2018 Nov 26
Publications & Presentations
PubMed
- 292 citationsCyclic AMP: master regulator of innate immune cell function.Carlos H. Serezani, Megan N. Ballinger, David M. Aronoff, Marc Peters-Golden
American Journal of Respiratory Cell and Molecular Biology. 2008-03-06 - 50 citationsA clinical and epidemiological review of non-toxigenic Clostridium difficileMukil Natarajan, Seth T. Walk, Vincent B. Young, David M. Aronoff
Anaerobe. 2013-08-01 - 22 citationsE-prostanoid 2 receptor signaling suppresses lung innate immunity against Streptococcus pneumoniae.David M. Aronoff, Ingrid L. Bergin, Casey Lewis, Deepti Goel, Edmund O'Brien
Prostaglandins & Other Lipid Mediators. 2012-05-01
Authored Content
- Food Safety and COVID-19April 2020
Press Mentions
COVID Drops to Fourth Leading Cause of Death, CDC SaysMay 4th, 2023- CDC Loosens Coronavirus Guidance, Signaling Strategic ShiftAugust 11th, 2022
- COVID Symptoms Usually Appear in This OrderJuly 3rd, 2022
- Join now to see all
Grant Support
- Epidemiology And Genomics Of Clostridium DifficileNational Institute Of Allergy And Infectious Diseases2010–2011
- Role Of Misoprostol In Clostridium Sordellii Endometritis After Medical AbortionEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2011
- Modulation Of Lung Innate Immunity Prostaglandin E2National Heart, Lung, And Blood Institute2006–2009
- Modulation Of Lung Innate Immunity By Prostaglandin E2National Heart, Lung, And Blood Institute2005–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
